Home Cart Sign in  
Chemical Structure| 133099-07-7 Chemical Structure| 133099-07-7
Chemical Structure| 133099-07-7

Darifenacin hydrobromide

CAS No.: 133099-07-7

Darifenacin hydrobromide is a M3-selective antagonist with pKi of 8.9, an anticholinergic and antispasmotic agent used to treat urinary incontinence and overactive bladder syndrome.

Synonyms: UK-88525 hydrobromide; Darifenacin(hydrobromide); UK 88525-04

4.5 *For Research Use Only !

Cat. No.: A211196 Purity: 98%

Change View

Size Price

US Stock

Global Stock

In Stock
10mg łÇʶÊÊ Inquiry Inquiry
25mg łÇ˶ÊÊ Inquiry Inquiry
50mg łÇÿ¶ÊÊ Inquiry Inquiry
100mg łÇî¶ÊÊ Inquiry Inquiry
250mg łËÿ¶ÊÊ Inquiry Inquiry
1g łÿď¶ÊÊ Inquiry Inquiry
5g łÇďǶÊÊ Inquiry Inquiry
25g łòÊǶÊÊ Inquiry Inquiry

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 10mg

    łÇʶÊÊ

  • 25mg

    łÇ˶ÊÊ

  • 50mg

    łÇÿ¶ÊÊ

  • 100mg

    łÇî¶ÊÊ

  • 250mg

    łËÿ¶ÊÊ

  • 1g

    łÿď¶ÊÊ

  • 5g

    łÇďǶÊÊ

  • 25g

    łòÊǶÊÊ

In Stock

- +

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Alternative Products

Product Details of Darifenacin hydrobromide

CAS No. :133099-07-7
Formula : C28H31BrN2O2
M.W : 507.46
SMILES Code : O=C(C(C1=CC=CC=C1)([C@H]2CN(CC2)CCC3=CC4=C(C=C3)OCC4)C5=CC=CC=C5)N.Br
Synonyms :
UK-88525 hydrobromide; Darifenacin(hydrobromide); UK 88525-04
InChI Key :UQAVIASOPREUIT-VQIWEWKSSA-N
Pubchem ID :444030

Safety of Darifenacin hydrobromide

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • mAChR

    M3 mAChR, pKi:8.9

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.97mL

0.39mL

0.20mL

9.85mL

1.97mL

0.99mL

19.71mL

3.94mL

1.97mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories